Construction of a new clinical staging system for colorectal cancer based on the lymph node ratio: A validation study

被引:2
|
作者
Yang, Yan [1 ,2 ]
Wang, Yawei [2 ,3 ]
Wang, Zhengbin [4 ]
机构
[1] Yangzhou Univ, Jiangdu Peoples Hosp Affiliated, Med Coll, Dept Gen Surg, Yangzhou, Peoples R China
[2] Yangzhou Univ, Northern Jiangsu Peoples Hosp affiliated, Clin Med Sch, Dept Gastrointestinal Surg, Yangzhou, Peoples R China
[3] Jiangsu Hosp Integrated Tradit Chinese & Western M, Dept Gen Surg, Nanjing, Peoples R China
[4] Yangzhou Univ, Affiliated Hosp, Dept Gastrointestinal Surg, Yangzhou, Peoples R China
来源
FRONTIERS IN SURGERY | 2022年 / 9卷
关键词
lymph node ratio; AJCC staging system; colorectal cancer; survival; CRC; COLON-CANCER; PROGNOSTIC VALUE; RECTAL-CANCER; 8TH EDITION; SURVIVAL; EPIDEMIOLOGY; SURVEILLANCE; COMBINATION; RESECTION; TUMOR;
D O I
10.3389/fsurg.2022.929576
中图分类号
R61 [外科手术学];
学科分类号
摘要
Aim: This study aims to construct a new staging system for colorectal cancer (CRC) based on the lymph node ratio (LNR) as a supplement to the American Joint Committee on Cancer (AJCC) tumor node metastasis (TNM) staging system for predicting the prognosis of CRC patients with ,12 lymph rodes. Methods: The data of 26,695 CRC patients with < 12 lymph nodes were extracted from the Surveillance, Epidemiology, and End Results (SEER) database as a training set. A total of 635 CRC patients were also enrolled from Northern Jiangsu People's Hospital affiliated with Yangzhou University as an independent validation set. Classification and regression tree analysis was used to obtain the LNR cutoff value. Survival curves were estimated using the Kaplan-Meier method, and the log-rank test was used for comparisons of differences among the survival curves. The monotonic decreasing trend of the overall survival curve in the staging system was expressed by the linear correlation degree R. Results: The 5-year survival rates of patients in the training set based on the AJCC staging system from stage I to stage IV were 75.6% (95%CI: 74.4-76.8), 59.8% (95%CI: 58.6-61.0), 42.1% (95%CI: 34.5-49.7), 33.2% (95%CI: 24.6-41.8), 72.0% (95%CI: 69.1-74.9), 48.8% (95%CI: 47.4-50.2), 26.5% (95%CI: 23.0-30.0), and 11.3% (95%CI: 10.3-12.3). The 5-year survival rates of patients in the training set from stage I to stage IIIC were 80.4%, 72.9%, 59.8%, 48.4%, 32.5%, and 15.0%, according to the TNM + LNR (TNRM) staging system. According to the AJCC staging system, the 5-year survival rates of patients in the validation set from stage I to stage IIIC were 91.3%, 90.8%, 72.6%, 61.3%, 72.4%, 58.1%, and 32.8%. Based on the TNRM staging system, the 5-year survival rates of patients in the validation set from stage I to stage IIIC were 99.2%, 90.5%, 81.4%, 78.6%, 60.2%, and 35.8%. Conclusion: The TNRM staging system successfully eliminated "survival paradox " in the AJCC staging system, which might be superior to the AJCC staging system.
引用
收藏
页数:12
相关论文
共 50 条
  • [41] Accurate staging of colorectal cancer by sentinel lymph node mapping. A prospective study
    Saha, S
    Espinosa, M
    Wiese, D
    Gauthier, J
    Nora, D
    Dorman, S
    Ganatra, BK
    Desai, D
    Singh, T
    Arora, M
    17TH INTERNATIONAL CANCER CONGRESS, VOL 1 AND 2, 1998, : 1005 - 1011
  • [42] Lymph node ratio-based staging system for esophageal squamous cell carcinoma
    Shao-Bin Chen
    Hong-Rui Weng
    Geng Wang
    Xiao-Fang Zou
    Di-Tian Liu
    Yu-Ping Chen
    Hao Zhang
    World Journal of Gastroenterology, 2015, 21 (24) : 7514 - 7521
  • [43] Lymph node ratio-based staging system for esophageal squamous cell carcinoma
    Chen, Shao-Bin
    Weng, Hong-Rui
    Wang, Geng
    Zou, Xiao-Fang
    Liu, Di-Tian
    Chen, Yu-Ping
    Zhang, Hao
    WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (24) : 7514 - 7521
  • [44] Lymph node ratio-based the ypTNrM staging system for gastric cancer after neoadjuvant therapy: a large population-based study
    Chen, Jia-Xian
    Sun, Jian-Wei
    Wang, Yi
    Pan, Tao
    Zhuang, Lv-Ping
    Lin, Li-Zhen
    Lv, Bang-Ce
    SURGERY TODAY, 2022, 52 (05) : 783 - 794
  • [45] Lymph node ratio-based the ypTNrM staging system for gastric cancer after neoadjuvant therapy: a large population-based study
    Jia-Xian Chen
    Jian-Wei Sun
    Yi Wang
    Tao Pan
    Lv-Ping Zhuang
    Li-Zhen Lin
    Bang-Ce Lv
    Surgery Today, 2022, 52 : 783 - 794
  • [46] Superiority of lymph node ratio-based staging system for prognostic prediction in 2575 patients with gastric cancer: validation analysis in a large single center
    Zhao, Lin-Yong
    Li, Chang-Chun
    Jia, Lu-Yu
    Chen, Xiao-Long
    Zhang, Wei-Han
    Chen, Xin-Zu
    Yang, Kun
    Liu, Kai
    Wang, Yi-Gao
    Xue, Lian
    Zhang, Bo
    Chen, Zhi-Xin
    Chen, Jia-Ping
    Zhou, Zong-Guang
    Hu, Jian-Kun
    ONCOTARGET, 2016, 7 (32) : 51069 - 51081
  • [47] A Lymph Node Ratio-Based Staging Model Is Superior to the Current Staging System for Pancreatic Neuroendocrine Tumors
    Gaitanidis, Apostolos
    Patel, Dhaval
    Nilubol, Naris
    Tirosh, Amit
    Kebebew, Electron
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2018, 103 (01): : 187 - 195
  • [48] Lymph Node Ratio Should Be Considered for Incorporation into Staging for Breast Cancer
    Chagpar, Anees B.
    Camp, Robert L.
    Rimm, David L.
    ANNALS OF SURGICAL ONCOLOGY, 2011, 18 (11) : 3143 - 3148
  • [49] Challenges in Staging Systems for Colorectal Cancer: Clinical Significance of Metastatic Lymph Node Number in Colorectal Cancer and Mesorectal Extension in Rectal Cancer
    Akagi, Yoshito
    Fukushima, Takanaru
    Mizobe, Tomoaki
    Shiratsuchi, Ichitaro
    Ryu, Yasuhiko
    Yoshida, Takefumi
    Ishibashi, Nobuya
    Kinugasa, Tetsushi
    Shirouzu, Kazuo
    DIGESTION, 2010, 82 (03) : 192 - 197
  • [50] Lymph Node Ratio Should Be Considered for Incorporation into Staging for Breast Cancer
    Anees B. Chagpar
    Robert L. Camp
    David L. Rimm
    Annals of Surgical Oncology, 2011, 18 : 3143 - 3148